Intangible Assets

DHAI appears to have some proprietary know-how and product differentiation, but the absence of disclosed long-run margin history makes it hard to show that these assets sustain pricing power better than peers.

The company’s high TTM ROIC of 37.5% suggests its offerings can earn attractive returns, yet without filing evidence of patents, regulatory exclusivity, or brand-led premium pricing, the intangible moat looks more limited than stronger peers.

Compared with peers that have protected IP, regulated licenses, or deeply embedded clinical workflows, DHAI’s intangible assets look more execution-dependent and therefore more replicable over a 5–10 year horizon.

Switching Costs

DHAI’s TTM ROCE of 30.2% and asset turnover of 2.35x indicate customers are using the product efficiently, but these metrics alone do not prove that customers would face high economic or operational costs to switch.

If DHAI is embedded in recurring workflows or data-dependent processes, that would support retention, but the provided evidence does not show peer-leading lock-in or contractual stickiness.

Relative to peers with mission-critical software, regulated service integration, or high retraining costs, DHAI’s switching costs appear present but not yet clearly superior.

Network Effects

No filing-based evidence was provided that DHAI benefits from a two-sided marketplace, user-to-user interaction, or data network effects that compound with scale.

The company’s profitability suggests some operating leverage, but that is not the same as a self-reinforcing network that improves retention and pricing power versus peers.

Compared with platform peers where each additional user materially increases product value, DHAI’s network effects appear limited or unproven.

Cost Advantage

DHAI’s strong ROIC and ROCE imply it can convert capital into earnings efficiently, which is consistent with some cost discipline or process advantage.

However, the provided metrics do not show a structural input-cost edge, scale purchasing power, or manufacturing advantage that would clearly persist versus peers.

Relative to peers with lower unit costs or advantaged supply chains, DHAI looks efficient but not demonstrably advantaged enough to claim a durable cost moat.

Efficient Scale

The available evidence does not show that DHAI operates in a market where a small number of firms can profitably serve the whole demand base, which is the core condition for efficient-scale protection.

High asset turnover can support efficient operations, but it does not by itself prove that the market is too small for additional entrants to earn acceptable returns.

Compared with peers in highly concentrated or regulated niches, DHAI’s efficient-scale advantage is not clearly established from the data provided.

Overall Score

DHAI shows solid profitability and capital efficiency, but the provided evidence does not establish a peer-leading structural moat from filings or other tier-1 sources. The strongest support is moderate switching-cost and cost-efficiency evidence, while intangible assets, network effects, and efficient scale remain unproven relative to stronger peers, leaving the overall moat durable but not exceptional.